SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Sir John Franklin

PatientSir John Franklin
Date of birth1967-04-16
IdentifiersMRN HR-EX005-SYN; SSN (made up) 000-05-3328
Document date2026-01-27
AuthorCordelia Ashby-Nwankwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of home blood pressure readings, seen the same day by wilderness and expedition medicine. [S]

History of Present Illness

Sir John returns with a week of home readings, taken morning and evening with a validated upper-arm monitor and a large cuff: the average of 28 readings is 144/90, with no reading below 132/84. He has cut his wine to one glass with dinner and his salt, and walks every day. He has no headaches, chest pain, breathlessness, palpitations or ankle swelling. He brought no urine sample to the intake visit and has not yet given one. The tuberculosis blood test drawn at intake is negative. He is seen this afternoon by Dr. Okafor-Lindqvist of wilderness and expedition medicine. [S]

ElementDetail
Home readingsSeven-day average 144/90 mmHg (28 readings)
Office reading148/92 mmHg
SymptomsNone
LifestyleOne glass of wine with dinner; less salt; daily walks
Tuberculosis blood testNegative

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
RespiratoryNegativeNo breathlessness
NeurologicalNegativeNo headache or visual change
PsychiatricNegativeMood good; looking forward to the command

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet once dailyOne tablet by mouth every morningOral route2026-01-27activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar wintersOne tablet by mouth dailyOral route2026-01-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-01-27Body height170cmS
2026-01-27Body weight90.4kgS
2026-01-27Body mass index (BMI) [Ratio]31.3kg/m2S
2026-01-27Systolic blood pressure148mm[Hg]S
2026-01-27Diastolic blood pressure92mm[Hg]S
2026-01-27Heart rate76/minS
2026-01-27Respiratory rate14/minS
2026-01-27Body temperature36.6CelS
2026-01-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Physical Exam

Vital signs recorded on 2026-01-27; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 148/92, pulse 76; weight 90.4 kg, BMI 31.3; waist 106 cm
EyesFundi: no arteriovenous nicking, hemorrhages or exudates
CardiovascularRegular rhythm; no murmur or gallop; no carotid or abdominal bruit; foot pulses present; no edema

Problems

ProblemClinical statusVerificationCodeProvenance
High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirmresolvedconfirmed R03.0S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension.
Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; syntheticactiveconfirmed I10S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded.
Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and foodactiveconfirmed E66.811S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded.
Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation planactiveconfirmed Z71.84S — Synthetic travel-health problem anchored to the documented expedition.
Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy roomsactiveconfirmed H83.3X3S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic.
Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness aheadactiveconfirmed E55.9S — Synthetic laboratory finding at intake.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure (seated, five minutes' rest, large cuff, average of two readings)Every visitCompleted today148/92 mmHg
Self-managementHome blood pressure monitoringAt diagnosis and two to four weeks after each treatment change, then weeklyCompleted todaySeven-day average 144/90 mmHg confirms stage 2 hypertension; repeat a week before the next visit
ExaminationWeight, BMI and waistEvery visitCompleted today90.4 kg, BMI 31.3, waist 106 cm
ExaminationCardiac auscultationEvery visitCompleted todayNo murmur or gallop
ExaminationFundoscopic examinationYearlyCompleted todayNo hypertensive retinopathy
LaboratoryBasic metabolic panel, potassium and eGFRYearly (every six months only on a diuretic or renin-angiotensin blocker)Up to dateNormal at intake: sodium 140, potassium 4.2, creatinine 0.98 mg/dL, eGFR 88
LaboratoryLipid panelYearlyUp to dateAt intake: total cholesterol 188, HDL 52, LDL 112, triglycerides 120 mg/dL
LaboratoryHbA1c or fasting glucoseYearlyUp to dateHbA1c 5.6% at intake
LaboratoryUrine albumin-to-creatinine ratioAt diagnosis, then yearlyDeferredThe urine sample planned at intake was not collected, and none was given today. Without it, early kidney damage cannot be excluded, but creatinine, eGFR and the fundi are normal, so no harm is likely in the next few weeks. Corrective action: a urine cup given today and a standing order for the next visit
LaboratoryTSHAt diagnosisUp to date1.9 mIU/L at intake
Imaging12-lead ECGAt diagnosisUp to dateNormal at intake; no left ventricular hypertrophy
ImagingEchocardiogramAt diagnosis of stage 2 hypertension or suspected left ventricular hypertrophyOrderedBooked before the four-week review
ImagingRenal ultrasound or renal artery imagingOnly for resistant hypertension or a suspected secondary causeNot indicatedNo features of a secondary cause; potassium normal
ExaminationAnkle-brachial indexEvery two to three years from 65 or with a smoking historyNot indicatedAge 58 and never smoked; foot pulses present
SurveyCardiovascular risk (PREVENT and Pooled Cohort Equations)YearlyCompleted todayPREVENT about 6 percent; Pooled Cohort Equations about 8 percent; statin declined for now
SurveyPHQ-9 depression screenYearlyUp to datePHQ-9 3 at intake, item 9 scored 0
Medication safetyAmlodipine safety: ankle swelling, dizziness, flushingWhen started and at each visitCompleted todayStarted today; told to report ankle swelling or dizziness
ReferralWilderness and expedition medicine consultationBefore clearance for remote dutyCompleted todaySeen by Dr. Okafor-Lindqvist today
ExaminationExercise treadmill test before strenuous remote workBefore clearanceOrderedBooked in four weeks
Self-managementNutrition and food safety for the expedition (vitamin C and D, rations, cans, lead, botulism)Before departureCompleted todayVitamin D3 started; vitamin C plan and food-safety advice given

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and hyperlipidemia monographs (2026); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (2024); Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021 (2021); Recommendations for medical management of adult lead exposure (2007); Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions (2018); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022)

Follow-up: Echocardiogram and urine sample before the four-week review. Home readings for a week before then. Call for chest pain, breathlessness, fainting or ankle swelling. Next scheduled visit 2026-02-24: four-week review after starting amlodipine: blood pressure, side effects, echocardiogram and urine albumin. [S]